OFI Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$1.36M Buy
4,993
+536
+12% +$165K 0.09% 237
2015
Q2
$1.35M Buy
4,457
+760
+21% +$227K 0.08% 280
2015
Q1
$1.1M Buy
3,697
+114
+3% +$32.5K 0.07% 349
2014
Q4
$922K Buy
3,583
+251
+8% +$62.7K 0.06% 385
2014
Q3
$804K Sell
3,332
-21
-0.6% -$4.7K 0.06% 394
2014
Q2
$748K Buy
3,353
+517
+18% +$107K 0.05% 435
2014
Q1
$584K Sell
2,836
-392
-12% -$77.6K 0.05% 494
2013
Q4
$542K Buy
3,228
+44
+1% +$6.88K 0.04% 513
2013
Q3
$458K Buy
3,184
+68
+2% +$9.06K 0.04% 489
2013
Q2
$393K Buy
+3,116
New +$353K 0.04% 498

Other funds holding AGN

OFI Advisors's AGN Position: Q3 2015 in Review

OFI Advisors increased its Allergan plc (AGN) stake by 12% in Q3 2015, buying an estimated $165K and bringing the position to 4,993 shares worth $1.36M. The position accounts for 0.09% of the portfolio, ranked #237.

OFI Advisors first reported a position in AGN in Q2 2013 and has held it in 10 quarters since. 1,056 funds tracked by Wall St. Rank hold AGN as of Q3 2015.

  • OFI Advisors held 4,993 shares of Allergan plc worth $1.36M as of Q3 2015.
  • OFI Advisors bought 536 Allergan plc shares in Q3 2015, an estimated $165K.
  • Allergan plc made up 0.09% of OFI Advisors's portfolio in Q3 2015, its #237 holding.
  • OFI Advisors first reported a position in Allergan plc in Q2 2013 and has held it in 10 quarters since.
  • 1,056 funds tracked by Wall St. Rank held Allergan plc as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.